Liu T, Chambers B, Diehl A D, Van Kaer L, Jondal M, Ljunggren H G
Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Sweden.
J Immunol. 1997 Dec 1;159(11):5364-71.
Immunization of C57BL/6 (B6) mice with heat-killed Sendai virus generates a Sendai virus-specific CD8+ T cell response. This suggests that APC have the capacity to take up and present exogenous (nonreplicative) Sendai virus Ag on MHC class I molecules. Little is known about the intracellular requirements for processing of this form of Ag and its presentation on MHC class I. Therefore, we have studied the processing and presentation of heat-killed Sendai virus Ag on MHC class I molecules in splenic APC. Heat-killed Sendai virus Ags were efficiently processed by normal B6 as well as by TAP-1(-/-) splenic APC. Presentation was MHC class I restricted, since no presentation was seen by APC from TAP-1/beta2m-/- mice that lack expression of MHC class I. Presentation occurred even in the presence of brefeldin A, but was blocked by cytochalasin D as well as chloroquine. Finally, B6 as well as TAP-1(-/-) splenic APC, loaded with heat-killed Sendai virus Ag in vitro, primed naive CD8+ T cells in vivo. These studies suggest the existence of a TAP-independent pathway for Ag presentation on MHC class I in normal splenic APC, bearing many similarities with the MHC class II pathway for Ag presentation. The present results are discussed in relation to the events underlying the processing and presentation of exogenous Ag on MHC class I, the molecular basis for CD8+ T cell priming during viral infections, and prospects for vaccine development.
用热灭活仙台病毒免疫C57BL/6(B6)小鼠可产生仙台病毒特异性CD8+T细胞应答。这表明抗原呈递细胞(APC)有能力摄取外源性(非复制性)仙台病毒抗原并将其呈递于MHC I类分子上。对于这种形式的抗原加工及其在MHC I类分子上的呈递的细胞内要求知之甚少。因此,我们研究了热灭活仙台病毒抗原在脾脏APC中于MHC I类分子上的加工和呈递。热灭活仙台病毒抗原能被正常B6以及TAP-1基因敲除(-/-)的脾脏APC有效加工。呈递受MHC I类分子限制,因为缺乏MHC I类分子表达的TAP-1/β2微球蛋白双基因敲除(-/-)小鼠的APC未见呈递。即使在存在布雷菲德菌素A的情况下呈递仍会发生,但被细胞松弛素D以及氯喹阻断。最后,体外负载热灭活仙台病毒抗原的B6以及TAP-1(-/-)脾脏APC在体内可激活初始CD8+T细胞。这些研究表明在正常脾脏APC中存在一条不依赖TAP的抗原在MHC I类分子上呈递的途径,这与抗原在MHC II类分子上呈递的途径有许多相似之处。本文结果结合外源性抗原在MHC I类分子上加工和呈递的相关事件、病毒感染期间CD8+T细胞激活的分子基础以及疫苗开发前景进行了讨论。